Work

Supplementary Figure from Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure from Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy

DOI: 10.1158/2326-6066.22544187

Authors: Aiping Jiang, Yan Qin, Timothy A. Springer

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362620649

Cites:

Cited by:

Related to: 10